What to DO NOW Entering the first quarter of 2013

What to DO NOW

Entering the first quarter of 2013 you must OVERWEIGHT CTIX AND CLSN. These companys are entering a critical PHASE in the CATALYST NEWS CYCLE. CLSN will report FINAL DATA from their PHASE III HEAT trial which is their PATH to FDA approval. CTIX will be reporting results from the QPCR tests that will validate the ACTIVATION of P53 in humans as well as their first reports on TUMOR SHRINKAGE. Letting other members of the MAG7 rest during this period poses little danger of missing the "TRAIN" because their CATALYST GRADE reports are not due until LATER in the year.